{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:54:03Z","timestamp":1788688443515,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007352","name":"Swiss State Secretariat for Education Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpx.2025.100451","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:37:54Z","timestamp":1763653074000},"page":"100451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Iontophoretic delivery of caspofungin acetate to the cornea and sclera and its intracorneal biodistribution"],"prefix":"10.1016","volume":"10","author":[{"given":"Laura Gisela","family":"Gonz\u00e1lez Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeshvar N.","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2025.100451_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12281-013-0150-1","article-title":"Current Thoughts in Fungal Keratitis: Diagnosis and Treatment","volume":"7","author":"Ansari","year":"2013","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.ijpx.2025.100451_bb0010","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1167\/iovs.14-15662","article-title":"Optical coherence tomography and confocal microscopy following three different protocols of corneal collagen-crosslinking in keratoconus","volume":"55","author":"Bouheraoua","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2025.100451_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.ijpx.2025.100451_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpx.2025.100451_bb0025","series-title":"Device and Method for Corneal Delivery of Riboflavin by Iontophoresis for the Treatment of Keratoconus","first-page":"10","author":"Foschini","year":"2012"},{"key":"10.1016\/j.ijpx.2025.100451_bb0030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/AAC.49.4.1359-1363.2005","article-title":"Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model","volume":"49","author":"Goldblum","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpx.2025.100451_bb0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00417-006-0460-x","article-title":"Ocular penetration of caspofungin in a rabbit uveitis model","volume":"245","author":"Goldblum","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpx.2025.100451_bb0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17425247.2017.1266334","article-title":"Basic principles and current status of transcorneal and transscleral iontophoresis","volume":"14","author":"Gratieri","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2025.100451_bb0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0161-6420(89)32832-6","article-title":"Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye","volume":"96","author":"Grossman","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpx.2025.100451_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2010.07.107","article-title":"Trans-scleral iontophoretic delivery of low molecular weight therapeutics","volume":"147","author":"Gungor","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100451_bb0055","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/ajhp\/58.13.1206","article-title":"Caspofungin acetate: an antifungal agent","volume":"58","author":"Hoang","year":"2001","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijpx.2025.100451_bb0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archophthalmol.2010.110","article-title":"Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole","volume":"128","author":"Hurtado-Sarrio","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpx.2025.100451_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2012.08.037","article-title":"Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro","volume":"438","author":"Kalaria","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100451_bb0070","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1021\/mp4004173","article-title":"Controlled Iontophoretic Transport of Huperzine a across Skin in Vitro and in Vivo: effect of delivery Conditions and Comparison of Pharmacokinetic Models","volume":"10","author":"Kalaria","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2025.100451_bb0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.addr.2003.10.026","article-title":"Iontophoretic drug delivery","volume":"56","author":"Kalia","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2025.100451_bb0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0301-4738.185592","article-title":"Recent advances in diagnosis and management of Mycotic Keratitis","volume":"64","author":"Maharana","year":"2016","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ijpx.2025.100451_bb0085","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1023\/A:1013318412527","article-title":"Contributions of electromigration and electroosmosis to iontophoretic drug delivery","volume":"18","author":"Marro","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2025.100451_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3928\/1081597X-20200406-02","article-title":"Iontophoresis Corneal Cross-linking with Enhanced Fluence and Pulsed UV-A Light: 3-Year Clinical results","volume":"36","author":"Mazzotta","year":"2020","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ijpx.2025.100451_bb0095","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/mp500332m","article-title":"On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein","volume":"11","author":"Mun","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2025.100451_bb0100","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/AAC.01175-10","article-title":"Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous","volume":"55","author":"Neoh","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpx.2025.100451_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2014.04.008","article-title":"Clinical utility of caspofungin eye drops in fungal keratitis","volume":"44","author":"Neoh","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpx.2025.100451_bb0110","first-page":"259","article-title":"Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability","volume":"15","author":"Nicoli","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ijpx.2025.100451_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100451_bb0120","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100451_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40588-020-00142-8","article-title":"Fungal Infections of the Eye","volume":"7","author":"Rammohan","year":"2020","journal-title":"Curr Clin Microbiol"},{"key":"10.1016\/j.ijpx.2025.100451_bb0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/cid\/ciq204","article-title":"Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents","volume":"52","author":"Riddell","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpx.2025.100451_bb0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpx.2025.100451_bb0140","article-title":"Intracorneal iontophoretic delivery of triamcinolone acetonide prodrugs: Physicochemical parameters guiding electroransport","volume":"2025","author":"Santer","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100451_bb0145","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1128\/AAC.03324-14","article-title":"Pharmacokinetics and safety of intravitreal caspofungin","volume":"58","author":"Shen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpx.2025.100451_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11090460","article-title":"Advanced Formulation Approaches for Ocular Drug delivery: State-Of-The-Art and recent Patents","volume":"11","author":"Souto","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2025.100451_bb0155","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ijpx.2025.100451_bb0160","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ajo.2007.02.016","article-title":"Clinical characteristics and outcome of Candida keratitis","volume":"143","author":"Sun","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpx.2025.100451_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00003226-200005000-00010","article-title":"Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania","volume":"19","author":"Tanure","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ijpx.2025.100451_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-019-00338-6","article-title":"Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives","volume":"13","author":"Thakkar","year":"2019","journal-title":"Curr Fungal Infect R"},{"key":"10.1016\/j.ijpx.2025.100451_bb0175","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4155\/bio-2019-0045","article-title":"Chromatographic methods for echinocandin antifungal drugs determination in bioanalysis","volume":"11","author":"Uribe","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijpx.2025.100451_bb0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000187627","article-title":"Aqueous humor concentrations of topically administered caspofungin in rabbits","volume":"41","author":"Vorwerk","year":"2009","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ijpx.2025.100451_bb0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-014-2287-4","article-title":"Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs","volume":"34","author":"Wang","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijpx.2025.100451_bb0190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1248\/cpb.c13-00548","article-title":"Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers","volume":"61","author":"Yamamoto","year":"2013","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.ijpx.2025.100451_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00003226-200201000-00029","article-title":"Iontophoresis for the Treatment of Paecilomyces Keratitis","volume":"21","author":"Yoo","year":"2002","journal-title":"Cornea"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:20:06Z","timestamp":1773832806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156725001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"alternative-id":["S2590156725001367"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100451","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iontophoretic delivery of caspofungin acetate to the cornea and sclera and its intracorneal biodistribution","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100451"}}